NCT04045028 · Interventional trial
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Overall registry status Terminated
Phase 1
Conditions B-Cell Lymphoma, Multiple Myeloma, Non-Hodgkin Lymphoma
Delaware Valley sites
- University of Pennsylvania; School of Medicine · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory